1. In this randomized trial, upadacitinib dosed at 15mg with a 26-week glucocorticoid taper showed superior efficacy than placebo with...

1. In this randomized controlled trial, prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) was not associated with a reduction in the incidence...

1. In this randomized controlled trial of patients with pulmonary arterial hypertension (PAH) and high risk of mortality, sotatercept reduced...

1. In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in patients with type...

1. In this randomized controlled trial (CHAPAS-4), tenofovir alafenamide fumarate (TAF) with emtricitabine showed superior viral suppression at 96 weeks...

1. In this randomized controlled trial, oveporexton use significantly improved symptoms of narcolepsy over eight weeks.  2. Adverse events were...

1. In this prospective cohort study, treatment with atidarsagene autotemce (arsa-cel) significantly reduced the risk of severe motor impairment and death...

1. This case series identified three non-coding erythropoietin (EPO) variants that significantly increased gene expression under hypoxic conditions.  2. The...

1. In concurrent randomized controlled trials (GEMINI 1 and GEMINI 2) of patients with relapsing multiple sclerosis (RMS), tolebrutinib did...

1. In this randomized controlled trial of patients with posterior circulation stroke not for thrombectomy, treatment with alteplase 4.5 to...